RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$17.19
+0.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.17x
- PEG TTM
- —
- Price / book
- 0.97x
- Price / sales
- 141.37x
- Price / cash flow
- 3.47x
Enterprise value
- Enterprise value
- -$1.5M
- EV / sales
- -2.36x
- EV / EBITDA
- -0.06x
- EV / EBIT
- 0.06x
- Market cap
- $91.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026